{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:49:05Z","timestamp":1791074945938,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The long-term dose-effect relationship for specific cardiac structures in mediastinal radiotherapy has rarely been investigated. As part of an interdisciplinary project, the 3-D dose distribution within the heart was reconstructed in all long-term Hodgkin's disease survivors (n = 55) treated with mediastinal radiotherapy between 1978 and 1985. For dose reconstruction, original techniques were transferred to the CT data sets of appropriate test patients, in whom left (LV) and right ventricle (RV), left (LA) and right atrium (RA) as well as right (RCA), left anterior descending (LAD) and left circumflex (LCX) coronary arteries were contoured. Dose-volume histograms (DVHs) were generated for these heart structures and results compared between techniques.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Predominant technique was an anterior mantle field (cobalt-60). 26 patients (47%) were treated with anterior mantle field alone (MF), 18 (33%) with anterior mantle field and monoaxial, bisegmental rotation boost (MF+ROT), 7 (13%) with anterior mantle field and dorsal boost (MF+DORS) and 4 (7%) with other techniques. Mean \u00b1 SD total mediastinal doses for MF+ROT (41.7 \u00b1 3.5 Gy) and for MF+DORS (42.7 \u00b1 7.4) were significantly higher than for MF (36.7 \u00b1 5.2 Gy). DVH analysis documented relative overdosage to right heart structures with MF (median maximal dose to RV 129%, to RCA 127%) which was siginificantly reduced to 117% and 112%, respectively, in MF+ROT. Absolute doses in right heart structures, however, did not differ between techniques. Absolute LA doses were significantly higher in MF+ROT patients than in MF patients where large parts of LA were blocked. Median maximal doses for all techniques ranged between 48 and 52 Gy (RV), 44 and 46 Gy (LV), 47 and 49 Gy (RA), 38 and 45 Gy (LA), 46 and 50 Gy (RCA), 39 and 44 Gy (LAD) and 34 and 42 Gy (LCX).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In patients irradiated with anterior mantle-field techniques, high doses to anterior heart portions were partly compensated by boost treatment from non-anterior angles. As the threshold doses for coronary artery disease, cardiomyopathy, pericarditis and valvular changes are assumed to be 30 to 40 Gy, cardiac toxicity must be anticipated in these patients. Thus, dose distributions in individual subjects should be correlated to the corresponding cardiovascular findings in these long-term survivors, e. g. by cardiovascular magnetic resonance imaging.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1748-717x-1-10","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T15:48:30Z","timestamp":1145548110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures"],"prefix":"10.1186","volume":"1","author":[{"given":"Dirk","family":"Vordermark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Seufert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"K\u00f6lbl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margret","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Angermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Flentje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,4,20]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1200\/JCO.2004.09.109","volume":"22","author":"MJ Adams","year":"2004","unstructured":"Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch P, Lipshultz SE: Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004, 22: 3139-3148. 10.1200\/JCO.2004.09.109","journal-title":"J Clin Oncol"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","volume":"21","author":"BM Aleman","year":"2003","unstructured":"Aleman BM, van den Belt-Dusebout AW, Klokman WJ, van't Veer MB, Bartelink H, van Leeuwen FE: Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003, 21: 3431-3439. 10.1200\/JCO.2003.07.131","journal-title":"J Clin Oncol"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0167-8140(97)00125-4","volume":"46","author":"C Glanzmann","year":"1998","unstructured":"Glanzmann C, Kaufmann P, Jenni R, Hess OM, Huguenin P: Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 1998, 46: 51-62. 10.1016\/S0167-8140(97)00125-4","journal-title":"Radiother Oncol"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/hrt.75.6.591","volume":"75","author":"MB Lund","year":"1996","unstructured":"Lund MB, Ihlen H, Voss BM, Abrahamsen AF, Nome O, Kongerud J, Stugaard M, Forfang K: Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart 1996, 75: 591-595.","journal-title":"Heart"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1148\/78.4.553","volume":"78","author":"HS Kaplan","year":"1962","unstructured":"Kaplan HS: The radical radiotherapy of regionally localized Hodgkin's disease. Radiology 1962, 78: 553-561.","journal-title":"Radiology"},{"key":"10_CR6","first-page":"881","volume-title":"Ann Intern Med","author":"VT De Vita","year":"1970","unstructured":"De Vita VT, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970, 881-895."},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1200\/JCO.2003.03.023","volume":"21","author":"A Engert","year":"2003","unstructured":"Engert A, Schiller P, Josting A, Herrmann R, Koch P, Sieber M, Boissevain F, De Wit M, Mezger J, Duhmke E, Willich N, Muller RP, Schmidt BF, Renner F, Muller-Hermelink HK, Pfistner B, Wolf J, Hasenclever D, Loffler M, Diehl V: German Hodgkin's Lymphoma Study Group. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2003, 21: 3601-3608. 10.1200\/JCO.2003.03.023","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10_CR8","first-page":"49","volume":"181","author":"HT Eich","year":"2005","unstructured":"Eich HT, M\u00fcller RP, Hansemann K: Results of the 4th interim analysis of the HD 11 trial of the GHSG for intermediate stage Hodgkin's lymphoma: 30 Gy vs. 20 Gy involved field radiotherapy [abstract]. Strahlenther Onkol 2005,181(suppl 1):49.","journal-title":"Strahlenther Onkol"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1040-8428(01)00227-X","volume":"45","author":"MJ Adams","year":"2003","unstructured":"Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE: Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 2003, 45: 55-75.","journal-title":"Crit Rev Oncol Hematol"},{"key":"10_CR10","first-page":"2813","volume":"37","author":"RJ Carmel","year":"1976","unstructured":"Carmel RJ, Kaplan HS: Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication and complications. Cancer 1976, 37: 2813-2825.","journal-title":"An analysis of technique, tumor eradication and complications. Cancer"},{"key":"10_CR11","first-page":"596","volume":"161","author":"K Musshoff","year":"1985","unstructured":"Musshoff K, Weidkuhn V, Bammert J, Felker HU: Diagnosis and therapy of Hodgkin's disease in Freiburg in Breisgau 1964 to 1976 [German]. Strahlenther 1985, 161: 596-614.","journal-title":"Strahlenther"},{"key":"10_CR12","first-page":"221","volume":"161","author":"U Schulz","year":"1985","unstructured":"Schulz U, Malewski U, Alberti W: Prognostic factors during control of the course of lymhogranulomatosis: comparison of 2 therapy technics and analysis of serologic parameters [German]. Strahlenther 1985, 161: 221-224.","journal-title":"Strahlenther"},{"key":"10_CR13","first-page":"393","volume":"164","author":"N Willich","year":"1988","unstructured":"Willich N, Bayer M, Krimmel K, Lengsfeld M, Rohloff R, Wendt T: A ventral mantle technic with dorsolateral mediastinal saturation in the radiotherapy of Hodgin's disease [German]. Strahlenther Onkol 1988, 164: 393-401.","journal-title":"Strahlenther Onkol"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/1097-0142(197503)35:3<795::AID-CNCR2820350335>3.0.CO;2-M","volume":"35","author":"R Byhardt","year":"1975","unstructured":"Byhardt R, Brace K, Ruckdeschel J, Chang P, Martin R, Wiernik P: Dose and treatment factors in radiation-related pericardial effusion associated with the mantle technique for Hodgkin's disease. Cancer 1975, 35: 795-802.","journal-title":"Cancer"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0140-6736(85)92089-6","volume":"1","author":"RS Coltart","year":"1985","unstructured":"Coltart RS, Roberts JT, Thom CH, et al.: Severe constrictive pericarditis after single 16 MeV anterior mantle irradiation for Hodgkin's disease. Lancet 1985, 1: 488-489. 10.1016\/S0140-6736(85)92089-6","journal-title":"Lancet"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1056\/NEJM198303103081005","volume":"308","author":"JS Gottdiener","year":"1983","unstructured":"Gottdiener JS, Katin MJ, Borer JS, Bacharach SL, Green MV: Late cardiac effects of therapeutic mediastinal irradiation. New Engl J Med 1983, 308: 569-572.","journal-title":"New Engl J Med"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","volume":"108","author":"JA McCrohon","year":"2003","unstructured":"McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennel DJ: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003, 108: 54-59. 10.1161\/01.CIR.0000078641.19365.4C","journal-title":"Circulation"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/0002-9149(87)90345-6","volume":"60","author":"PT McEniery","year":"1987","unstructured":"McEniery PT, Dorosti K, Schiavone W, Pedrick TJ, Sheldon WC: Clinical and angiographic features of coronary artery disease after chest irradiation. Am J Cardiol 1987, 60: 1020-1024. 10.1016\/0002-9149(87)90345-6","journal-title":"Am J Cardiol"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0167-8140(94)90008-6","volume":"30","author":"C Glanzmann","year":"1994","unstructured":"Glanzmann C, Huguenin P, L\u00fctolf UM, Maire R, Jenni R, Gumppenberg V: Cardiac lesions after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 1994, 30: 43-54. 10.1016\/0167-8140(94)90008-6","journal-title":"Radiother Oncol"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1200\/JCO.2005.05.288","volume":"23","author":"D Vordermark","year":"2005","unstructured":"Vordermark D, Seufert I, Schwab F, Flentje M, Kung M, Angermann C: Cardiac toxicity of mediastinal radiotherapy: which are the critical structures? [letter]. J Clin Oncol 2005, 23: 3966-3967. 10.1200\/JCO.2005.05.288","journal-title":"J Clin Oncol"},{"key":"10_CR21","volume-title":"Thieme, Stuttgart","author":"K K\u00fcper","year":"2001","unstructured":"K\u00fcper K: MR\/CT-Atlas der Anatomie. Digitale Schnittbilddiagnostik [German]. Thieme, Stuttgart 2001."},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1378\/chest.118.2.488","volume":"118","author":"DN Rabin","year":"2000","unstructured":"Rabin DN, Rabin S, Mintzer RA: A pictorial review of coronary artery anatomy on spiral CT. Chest 2000, 118: 488-491. 10.1378\/chest.118.2.488","journal-title":"Chest"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2214\/ajr.177.6.1771437","volume":"177","author":"A Sevrukov","year":"2001","unstructured":"Sevrukov A, Jelnin V, Kondos GT: Electron beam CT of the coronary arteries: cross-sectional anatomy for calcium scoring. Am J Roentgenol 2001, 177: 1437-1445.","journal-title":"Am J Roentgenol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-1-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T23:50:31Z","timestamp":1630453831000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-1-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,20]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-1-10","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,20]]},"assertion":[{"value":"10 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"10"}}